• Our company
• Our history

Xiamen Innovax Biotech CO., LTD. (INNOVAX) is a leading company in the field of developing, manufacturing and marketing innovative vaccines with its headquarter and manufacture base in Xiamen, China.

In collaboration with the National Institute of Diagnostics and Vaccine Development in Infectious Diseases (NIDVD), INNOVAX has established a core- platform using DNA recombinant technology to express protein in E. coli for vaccine production. Based on this platform, Hecolin^TM (Hepatitis E Vaccine) which is going to launch in the fourth quarter of 2011, a Cervical Cancer Vaccine which is in the clinical trial phase and a Genital Warts Vaccine which has been submitted for registration have been developed. Besides, there are two products in the pre-clinical development stage: a new HPV vaccine and a pediatric HEV vaccine.